When

Thursday June 23, 2016                                      

12:00 PM to 1:30 PM EST

Contact

Clinician Education Department 
Clinical Directors Network, Inc. (CDN)
New York NY 10018 
212-382-0669212-382-0669 Ext 243
eLearning2@CDNetwork.org 

Reducing Opioid Overdose Mortality:

 Role of Community-Administered Naloxone

Speakers:

Vennus Ballen, MD, MPH

Public Health/Preventive Medicine Resident,

New York City Department of Health and Mental Hygiene

 
Lara Maldjian, MPH

Acting Naloxone Program Coordinator,

Special Assistant to the Assistant Commissioner,

New York City Department of Health and Mental Hygiene

 

A Live Webcast Sponsored by:

 Opioid Post-Marketing Requirements Consortium (OPC)/Campbell Alliance (Purdue Pharma, LP; Actavis; Endo Pharmaceuticals; Janssen Pharmaceuticals; Mallinckrodt, LLC; Pfizer; Rhodes Pharmaceuticals, LP; Roxane Laboratories; and Zogenix), Clinical Directors Network, Inc.(CDN), N2 PBRN Virtual Training Series (AHRQ, Grant No. 1P30-HS-021667)

This webcast is pending for up to 1.5 Prescribed credits by the American Academy of Family Physicians (AAFP)